Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exclusion products an alternative to antimicrobials in animals?:

As the debate continues on the use of growth-promoting antibiotics in food producing animals, new research says that developing competitive exclusion products could be an alternative to industry's reliance on antimicrobials. Exclusion products are products containing live microorganisms isolated from the gastrointestinal tract of chickens and other animals. Research on the genetics of antimicrobial resistance, published in Animal Biotechnology, says that preventing infection should be the "ultimate goal, aided by the development of efficacious vaccines" and exclusion products. A better understanding of the ecological, biochemical and molecular aspects of antimicrobial resistance is also needed to develop new products that can improve the efficacy of currently available products, says the research. It notes that this should lead to better strategies for managing antimicrobial resistance and for limiting the growth of resistance. sita.shah@informa.com

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP006475

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel